» Articles » PMID: 22647365

The Therapeutic Potential of MicroRNAs in Cancer

Overview
Journal Cancer J
Specialty Oncology
Date 2012 Jun 1
PMID 22647365
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) have been uncovered as important posttranscriptional regulators of nearly every biological process in the cell. Furthermore, mounting evidence implies that miRNAs play key roles in the pathogenesis of cancer and that many miRNAs can function either as oncogenes or tumor suppressors. Thus, miRNAs have rapidly emerged as promising targets for the development of novel anticancer therapeutics. The development of miRNA-based cancer therapeutics relies on restoring the activity of tumor suppressor miRNAs using double-stranded miRNA mimics or inhibition of oncogenic miRNAs using single-stranded antisense oligonucleotides, termed antimiRs. In the present review, we focus on recent advancements in the discovery and development of miRNA-based cancer therapeutics using these 2 approaches. In addition, we summarize selected studies, in which modulation of miRNA activity in preclinical cancer models in vivo has demonstrated promising therapeutic potential.

Citing Articles

miR-3154 promotes glioblastoma proliferation and metastasis via targeting TP53INP1.

Lin X, Wu Q, Lei W, Wu D, Sheng J, Liang G Cell Div. 2024; 19(1):30.

PMID: 39487468 PMC: 11529598. DOI: 10.1186/s13008-024-00134-w.


Androgen receptor modulatory miR-1271-5p can promote hormone sensitive prostate cancer cell growth.

Kalofonou F, Leach D, Powell S, Waxman J, Fletcher C, Bevan C Front Oncol. 2024; 14:1440612.

PMID: 39267821 PMC: 11390458. DOI: 10.3389/fonc.2024.1440612.


Oligonucleotide therapies for nonalcoholic steatohepatitis.

Li S, Xiong F, Zhang S, Liu J, Gao G, Xie J Mol Ther Nucleic Acids. 2024; 35(2):102184.

PMID: 38665220 PMC: 11044058. DOI: 10.1016/j.omtn.2024.102184.


Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers.

Lin L, Wu Q, Lu F, Lei J, Zhou Y, Liu Y Front Oncol. 2023; 13:1184079.

PMID: 37810967 PMC: 10559910. DOI: 10.3389/fonc.2023.1184079.


A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs.

Villarreal-Garcia V, Estupinan-Jimenez J, Vivas-Mejia P, Gonzalez-Villasana V, Vazquez-Guillen J, Resendez-Perez D Front Oncol. 2022; 12:980694.

PMID: 36226048 PMC: 9548555. DOI: 10.3389/fonc.2022.980694.